Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

76.60
-2.0800-2.64%
Pre-market: 77.731.13+1.48%07:57 EDT
Volume:1.92M
Turnover:149.06M
Market Cap:15.00B
PE:-21.47
High:80.55
Open:79.99
Low:76.34
Close:78.68
52wk High:93.42
52wk Low:48.78
Shares:195.81M
Float Shares:167.00M
Volume Ratio:1.36
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-5.96
PE(LYR):-20.24

Loading ...

Bridgebio Pharma Director Jennifer E. Cook Reports Disposal of Common Shares Worth $13.1 Million

Reuters
·
Jul 14

Bridgebio Pharma is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 13

Bridgebio Grants 83,283 Restricted Stock Units to 37 New Employees Under Inducement Plan

Reuters
·
Jul 11

Bridgebio Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 11

Movement Alert|BridgeBio Pharma Falls 5.02% in Regular Trading, Broad Biotech Sector Selloff Triggers Profit-Taking After Recent Rally

Market Focus
·
Jul 11

Alnylam, Bridgebio Gain from Astrazeneca-ionis Drug Missing Target

Dow Jones
·
Jul 10

AstraZeneca PLC Stock (AZN) Moved Down by 6.72% on Jul 9: A Full Analysis

TradingKey
·
Jul 09

Bridgebio Pharma up over 14%, on Track for Record High Close

Dow Jones
·
Jul 09

Movement Alert|BridgeBio Pharma Rises 10.17% in Regular Trading, $1 Billion Preferred Equity Financing from KKR and Sixth Street to Accelerate Rare Disease Drug Commercialization

Market Focus
·
Jul 09

BridgeBio Pharma (BBIO) Receives a Buy from Piper Sandler

TIPRANKS
·
Jul 09

S&P 500 Futures Climb in Premarket Trading; Alnylam Pharmaceuticals, Bridgebio Pharma Lead

Dow Jones
·
Jul 09

Bridgebio Pharma Shares Rise 9.9%

THOMSON REUTERS
·
Jul 09

Movement Alert|BridgeBio Pharma Rises 5.31% in Pre-Market Trading, $1 Billion Preferred Equity Financing Fuels Rare Disease Pipeline Commercialization

Market Focus
·
Jul 09

Astrazeneca's Wainua Fails Key Heart Disease Trial, Shares Tumble

Reuters
·
Jul 09

Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD), Teva Pharmaceutical (TEVA) and BridgeBio Pharma (BBIO)

TIPRANKS
·
Jul 08

BridgeBio Pharma (BBIO) Gets a Buy from Jefferies

TIPRANKS
·
Jul 06

Bridgebio Raises up to $1 Billion in Convertible Preferred Equity Private Placement Led by Sixth Street

Reuters
·
Jul 03

Bridgebio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches

THOMSON REUTERS
·
Jul 01

Bridgebio Pharma - Sixth Street Funded $800 Mln; Healthcare Royalty Funded $133.9 Mln at Close

THOMSON REUTERS
·
Jul 01

Market Chatter: KKR, Sixth Street to Invest $1 Billion in BridgeBio Preferred Equity

MT Newswires Live
·
Jul 01